Aytu BioScience receives approval for clinical use of MiOXSYS in Australia

Aytu BioScience receives approval for clinical use of MiOXSYS in Australia

ENGLEWOOD -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced the... Read More

Tuesday November 7, 2017 0 comments Tags: Englewood, Aytu BioScience, MiOXSYS, Josh Disbrow

Aytu BioScience announces stock uplisting to NASDAQ Capital Market on Oct. 20

Aytu BioScience announces stock uplisting to NASDAQ Capital Market on Oct. 20

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced its shares of... Read More

Wednesday October 18, 2017 0 comments Tags: Englewood, Aytu BioScience, Josh Disbrow

Aytu reports strong prescription growth for Natesto low-T drug

Aytu reports strong prescription growth for Natesto low-T drug

ENGLEWOOD -- Aytu BioScience, Inc . (OTCQX: AYTUD), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that through... Read More

Tuesday September 26, 2017 0 comments Tags: Englewood, Aytu BioScience, Josh Disbrow, Natesto

Aytu BioScience announces subscriptions for $11.5M to fund Natesto, operations

Aytu BioScience announces subscriptions for $11.5M to fund Natesto, operations

ENGLEWOOD -- Aytu BioScience, Inc . (OTCQX: AYTU) a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced it received... Read More

Monday August 14, 2017 0 comments Tags: Aytu BioScience, Englewood, Natesto

Aytu BioScience expands MiOXSYS distribution network in Europe

Aytu BioScience expands MiOXSYS distribution network in Europe

ENGLEWOOD -- Aytu BioScience, Inc . (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced an exclusive... Read More

Friday July 14, 2017 0 comments Tags: Englewood, Aytu BioScience, Josh Disbrow, MiOXSYS, GryNumber Health

Aytu BioScience appoints Gregory Gould as permanent company CFO

Aytu BioScience appoints Gregory Gould as permanent company CFO

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced the hiring of ... Read More

Tuesday June 20, 2017 0 comments Tags: Aytu BioScience, Gregory Gould, Englewood, Josh Disbrow

Ampio appoints Tom Chilcott as interim CEO

Ampio appoints Tom Chilcott as interim CEO

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE MKT: AMPE) today announced it has not renewed the employment agreement of Gregory Gould , Ampio's chief financial officer, which expired on ... Read More

Tuesday June 13, 2017 0 comments Tags: Englewood, Ampio Pharmaceuticals, Gregory Gould, Tom Chilcott, Aytu BioScience

Aytu BioScience acquires Nuelle female sexual health company

Aytu BioScience acquires Nuelle female sexual health company

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, announced the acquisition of... Read More

Wednesday May 10, 2017 0 comments Tags: Englewood, Aytu BioScience, Nuelle, Fiera, Josh Disbrow